Calamos Advisors’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Calamos Advisors’s Portfolio PEPLW Stock Details PEPLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-350,000	Closed	-$10.5K	–	1052
2023 Q4	$10.5K	Hold	350,000	–	–	﹤0.01%	850
2023 Q3	$24.9K	Hold	350,000	–	–	﹤0.01%	811
2023 Q2	$7.07K	Hold	350,000	–	–	﹤0.01%	937
2023 Q1	$33.3K	Hold	350,000	–	–	﹤0.01%	962
2022 Q4	$22.9K	Hold	350,000	–	–	﹤0.01%	1032
2022 Q3	$28K	Buy	+350,000	New	+$50.6K	﹤0.01%	1106

Other funds holding PEPLW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Calamos Advisors's PEPLW Position: Q1 2024 in Review

Calamos Advisors sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2024, closing a stake of 350,000 shares — an estimated $10.5K sold.

Calamos Advisors first reported a position in PEPLW in Q3 2022 and held it in 6 quarters. The position peaked at $33.3K in Q1 2023. 1 fund tracked by Wall St. Rank holds PEPLW as of Q1 2024.

Calamos Advisors reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2024 after selling out during the quarter.
Calamos Advisors sold 350,000 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2024, an estimated $10.5K.
Calamos Advisors first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q3 2022 and held it in 6 quarters.
Calamos Advisors's PepperLime Health Acquisition Corporation Warrrant position peaked at $33.3K in Q1 2023.
1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2024.

Based on Calamos Advisors's 13F filing for Q1 2024, filed 8 May 2024.